Yuji Nishiuchi Selected Research

Prodrugs

1/2018

A Novel Prodrug of a γ-Glutamylcyclotransferase Inhibitor Suppresses Cancer Cell Proliferation in vitro and Inhibits Tumor Growth in a Xenograft Mouse Model of Prostate Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yuji Nishiuchi Research Topics

Disease

3	Neoplasms (Cancer) 01/2018 - 11/2013
3	Pain (Aches) 07/2007 - 01/2006
2	Neuralgia (Stump Neuralgia) 07/2007 - 01/2006
1	Hypoglycemia (Reactive Hypoglycemia) 10/2021
1	Prostatic Neoplasms (Prostate Cancer) 01/2018
1	Alzheimer Disease (Alzheimer's Disease) 02/2004
1	Arteriosclerosis 02/2004
1	Cataract (Cataracts) 02/2004

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 11/2013 - 02/2004
3	nocistatinIBA 07/2007 - 01/2006
3	NociceptinIBA 07/2007 - 01/2006
2	NeuropeptidesIBA 07/2007 - 04/2006
2	Peptides (Polypeptides)IBA 07/2007 - 01/2006
1	Glucagon (Glukagon)FDA Link 10/2021
1	SolutionsIBA 10/2021
1	ProdrugsIBA 01/2018
1	Amino Acids FDA Link 03/2015
1	Pyrrolidonecarboxylic Acid (Pyroglutamic Acid)IBA 03/2015
1	Glutathione (Reduced Glutathione)IBA 11/2013
1	prepronociceptinIBA 01/2006
1	Aspartic Acid (Aspartate)FDA Link 02/2004

Therapy/Procedure

1	Therapeutics 01/2006